ERBB2 and triple-negative breast carcinoma: The comparisons of HER2-positive breast carcinoma, triple-negative breast cancer, and non-triple-negative breast cancer versus normal human breast organoids disclosed an up-regulation of nine POTE transcripts: ENST00000624267.3 (POTEB3), ENST00000511306.5 (POTEC), ENST00000358087.9 (POTEE), ENST00000361163.8 and ENST00000409914.6 (POTEF), ENST00000451531.6 and ENST00000652235.1 (POTEI), ENST00000397487.3 (POTEKP), and ENST00000552966.5 (POTEM) (Table S2).